// company-profile

Lyell Immunopharma, Inc.

LYEL
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings94Insiders32
// api This Lyell Immunopharma, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares versus 1 sale. Buying was led by FRIEDMAN CATHY.

// 90-day insight

Over the last 90 days, Lyell Immunopharma, Inc. insiders bought $0 (7 transactions) and sold $41K (5 transactions).

  • Most active insider: Shook David with 1 transaction totaling $25K.
  • Largest single sale: $25K by Shook David on Jun 10, 2026.

Activity is mixed — buys and sales are roughly balanced.

Institutional Ownership

Top 13F-HR holders of Lyell Immunopharma, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$235.0M
QoQ change
-31.9%
Reporting period
2026-03-31
#1
ARCH Venture Management, LLC
CIK 1274403
$65.1M
3.2M shares
#2
GSK plc
CIK 1131399
$30.3M
1.5M shares
#3
Foresite Capital Management IV, LLC
CIK 1704132
$16.1M
800K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 15, 2026Innovative Cellular Therapeutics Holdings LtdLYEL
J
66,500$0.00$0K
Jun 10, 2026FRIEDMAN CATHYLYEL
Award
9,250$0.00$0K
Jun 10, 2026Klausner RichardLYEL
Award
9,250$0.00$0K
Jun 10, 2026BRAWLEY OTIS WLYEL
Award
9,250$0.00$0K
Jun 10, 2026Shook DavidLYEL
Sale
1,977$12.64$25K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.